(Q58050845)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239907%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239907%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239907%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Chng WJ

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239907%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Gualberto A

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239907%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239907%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239907%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239907%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

174-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239907%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239907%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403997

8 January 2020

exact match

0 references

cites work

Insulin-like growth factors and neoplasia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403997

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403997

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403997

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403997

Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403997

inferred from DOI database lookup

7 January 2021

based on heuristic

Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403997

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239907%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference